Calcitonin receptors
Overview
This receptor family comprises a group of receptors for the calcitonin/CGRP family of peptides. The calcitonin (CT), amylin (AMY), calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) receptors are generated by the genes CALCR (which codes for the CT receptor) and CALCRL (which codes for the calcitonin receptor-like receptor, CLR, previously known as CRLR). Their function and pharmacology are altered in the presence of RAMPs (receptor activity-modifying proteins), which are single TM domain proteins of ca. 150 amino acids, identified as a family of three members; RAMP1, RAMP2 and RAMP3. There are splice variants of the CT receptor; these in turn produce variants of the AMY receptor [1], some of which can be potently activated by CGRP. The endogenous agonists are the peptides calcitonin, α-CGRP (formerly known as CGRP-I), β-CGRP (formerly known as CGRP-II), amylin (occasionally called islet-amyloid polypeptide, diabetes-associated polypeptide), adrenomedullin and adrenomedullin 2/intermedin. There are species differences in peptide sequences, particularly for the CTs. CTR-stimulating peptide (CRSP) is another member of the family with selectivity for the CT receptor but it is not expressed in humans [2]. CLR (calcitonin receptor-like receptor) by itself binds no known endogenous ligand, but in the presence of RAMPs it gives receptors for CGRP, adrenomedullin and adrenomedullin 2/intermedin. There are several approved drugs that target this receptor family, such as pramlintide, erenumab, and the "gepant" class of CGRP receptor antagonists.References
- Poyner DR, Sexton PM, Marshall I, et al. International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002;54:233-46.
- Katafuchi T, Kikumoto K, Hamano K, et al. Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family. Its isolation from porcine brain, structure, tissue distribution, and biological activity. J Biol Chem 2003;278:12046-54.
Excerpt from IUPHAR/BPS Guide to Pharmacology Filters Sort resultsReset ApplyFilters Sort resultsReset Apply
Species Receptor Family Assays Human AvailableAssay modes:Agonist⋅Inverse agonist⋅Antagonist⋅PAM⋅NAMPanels:Human non-orphan GPCRs⋅Immunology/Infection⋅Oncology⋅Hematology⋅Endocrinology/Metabolism⋅Ophthalmology⋅Cardiology⋅Respiratory⋅Gastrointestinal⋅Musculoskeletal⋅Urology/Reproduction⋅à la carte Human AvailableAssay modes:Agonist⋅Inverse agonist⋅Antagonist⋅PAM⋅NAMPanels:Human non-orphan GPCRs⋅à la carte Mouse AvailableAssay modes:Agonist⋅Inverse agonist⋅Antagonist⋅PAM⋅NAMPanels:Mouse non-orphan GPCRs⋅à la carte Mouse AvailableAssay modes:Agonist⋅Inverse agonist⋅Antagonist⋅PAM⋅NAMPanels:Mouse non-orphan GPCRs⋅à la cartePAGE TOP